Our mission and vision
- It is time to renovate and accelerate the discovery and development of drugs for rare diseases. Esperare is an essential player in the innovative, collaborative system that will be created to make a difference in this world.
- As a nonprofit organisation, our priorities are not determined by the size of a market, they are solely defined by the medical needs and great science. Above all, we strive to apply our patient-centric model and pharma know-how to advance new treatments for underserved patients.
- For me it is a privilege to represent Merck Serono on the Board of EspeRare, I firmly believe that this exciting new Foundation can make a real difference to the lives of patient’s with Duchenne Muscular Dystrophy and other rare diseases.